Comparison of treatments for persistent/chronic immune thrombocytopenia: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Comparison of treatments for persistent/chronic immune thrombocytopenia: a systematic review and network meta-analysis

Published:2018-12-03 Issue:8 Volume:30 Page:946-956
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Arai Yasuyuki¹²,Matsui Hiroyuki¹,Jo Tomoyasu¹,Kondo Tadakazu¹,Takaori-Kondo Akifumi¹

Affiliation:

1. Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

2. Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2018.1543864

Reference52 articles.

1. Immune Thrombocytopenic Purpura

2. Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management

3. Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study

4. The Bleeding Risk and Natural History of Idiopathic Thrombocytopenic Purpura in Patients With Persistent Low Platelet Counts

5. Clinical updates in adult immune thrombocytopenia

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials;Annals of Hematology;2024-06-10

2. Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada;Clinical and Investigative Medicine;2024-03-01

3. Efficacy and Safety of Fostamatinib in Refractory Immune Thrombocytopenia: A Meta-analysis from Randomized Controlled Trials;SSRN Electronic Journal;2024

4. Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study;Thrombosis Research;2022-12

5. Treatment Patterns and Outcomes of Second-Line Therapy in Adult Immune Thrombocytopenia: A Provincial Retrospective Cohort Study;SSRN Electronic Journal;2022